A 3-Case Series of Autoimmune Haemolytic Anaemia and COVID-19 : Is Plasma Exchange an Alternative?
© The Author(s), under exclusive licence to Springer Nature Switzerland AG 2021..
COVID-19 has rarely been associated with immune-mediated phenomena such as autoimmune haemolytic anaemia (AIHA). Both cold hemolysis with cold agglutinin detection and warm haemolysis have been described with variable prognoses. Current treatment regimens are based on experience with other case series and case reports, which still represent a clinical challenge. Corticosteroids, red cell transfusions and rituximab have been successfully employed. We present 3 cases of AIHA in the context of COVID-19 disease, the first case successfully treated with plasma exchange and long-term follow-up of the 3 cases showing complete remission of anaemia.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:3 |
|---|---|
| Enthalten in: |
SN comprehensive clinical medicine - 3(2021), 6 vom: 06., Seite 1420-1423 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ramos-Ruperto, L [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Autoimmune haemolytic anaemia |
|---|
| Anmerkungen: |
Date Revised 18.02.2022 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1007/s42399-021-00884-6 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM32424763X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM32424763X | ||
| 003 | DE-627 | ||
| 005 | 20231225185917.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s42399-021-00884-6 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1080.xml |
| 035 | |a (DE-627)NLM32424763X | ||
| 035 | |a (NLM)33870092 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ramos-Ruperto, L |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A 3-Case Series of Autoimmune Haemolytic Anaemia and COVID-19 |b Is Plasma Exchange an Alternative? |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 18.02.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2021. | ||
| 520 | |a COVID-19 has rarely been associated with immune-mediated phenomena such as autoimmune haemolytic anaemia (AIHA). Both cold hemolysis with cold agglutinin detection and warm haemolysis have been described with variable prognoses. Current treatment regimens are based on experience with other case series and case reports, which still represent a clinical challenge. Corticosteroids, red cell transfusions and rituximab have been successfully employed. We present 3 cases of AIHA in the context of COVID-19 disease, the first case successfully treated with plasma exchange and long-term follow-up of the 3 cases showing complete remission of anaemia | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Autoimmune haemolytic anaemia | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Corticosteroids | |
| 650 | 4 | |a Plasma exchange | |
| 700 | 1 | |a García-Pérez, Eduardo |e verfasserin |4 aut | |
| 700 | 1 | |a Hernández-Maraver, D |e verfasserin |4 aut | |
| 700 | 1 | |a Kerguelén-Fuentes, A |e verfasserin |4 aut | |
| 700 | 1 | |a Viejo-Llorente, A |e verfasserin |4 aut | |
| 700 | 1 | |a Robles-Marhuenda, Á |e verfasserin |4 aut | |
| 700 | 1 | |a Busca-Arenzana, C |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t SN comprehensive clinical medicine |d 2019 |g 3(2021), 6 vom: 06., Seite 1420-1423 |w (DE-627)NLM300071965 |x 2523-8973 |7 nnns |
| 773 | 1 | 8 | |g volume:3 |g year:2021 |g number:6 |g day:06 |g pages:1420-1423 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s42399-021-00884-6 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 3 |j 2021 |e 6 |b 06 |h 1420-1423 | ||